# STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

> **NCT03829371** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Turin, Italy** · enrollment: 450 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade
- **DRUG:** Melphalan
- **DRUG:** Prednisone
- **DRUG:** Lenalidomide
- **DRUG:** Dexamethasone
- **DRUG:** Daratumumab

## Key facts

- **NCT ID:** NCT03829371
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-03
- **Primary completion:** 2027-01-03
- **Final completion:** 2030-01-03
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03829371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03829371, "STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03829371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*